Document Detail

Hypertension in the postpartum woman: clinical update for the hypertension specialist.
MedLine Citation:
PMID:  20021530     Owner:  NLM     Status:  MEDLINE    
Hypertension can persist from pregnancy or present de novo in the postpartum period and continue to pose a risk to maternal well-being. These risks are magnified as many patients present after hospital discharge and go unrecognized because of decreased medical surveillance after delivery. Guidelines for the management of postpartum hypertension are lacking, often resulting in imprecise diagnoses and incorrect treatment strategies. As hypertension specialists are called upon to provide advice to obstetricians regarding the management of hypertension in the postpartum period, it becomes important for the hypertension specialist to develop expertise in the evaluation and treatment of hypertensive women during the postpartum period. The purpose of this clinical review article is to provide an approach to the management of postpartum hypertension.
Nimrta Ghuman; Jacqueline Rheiner; Beatriz E Tendler; William B White
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Journal of clinical hypertension (Greenwich, Conn.)     Volume:  11     ISSN:  1751-7176     ISO Abbreviation:  J Clin Hypertens (Greenwich)     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2009-12-21     Completed Date:  2010-03-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888554     Medline TA:  J Clin Hypertens (Greenwich)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  726-33     Citation Subset:  IM    
Division of Hypertension and Clinical Pharmacology, Pat and Jim Calhoun Cardiology Center, University of Connecticut School of Medicine, 263 Farmington Avenue, Farmington, CT 06030-3940, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / therapeutic use
Antihypertensive Agents / contraindications,  pharmacokinetics,  therapeutic use*
Calcium Channel Blockers / therapeutic use
Diuretics / therapeutic use
Dopamine Antagonists / therapeutic use
Hypertension, Pregnancy-Induced / diagnosis,  drug therapy*,  epidemiology,  etiology
Milk, Human / metabolism
Puerperal Disorders / diagnosis,  drug therapy*,  epidemiology,  etiology
Renin-Angiotensin System / drug effects
Risk Assessment
Risk Factors
United States / epidemiology
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Antihypertensive Agents; 0/Calcium Channel Blockers; 0/Diuretics; 0/Dopamine Antagonists

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure...
Next Document:  The metabolic syndrome: a modern plague spread by modern technology.